GlassScriptPhysician profile
Amos Z Dai
NPI 1730686742
$12,703.98
in general payments reported to CMS, 2019-2025
12 companies · $2,587 in 2025
The $2,587 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,400 · 2022: $2,187 · 2023: $3,020 · 2024: $2,510 · 2025: $2,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,936 · Travel and Lodging: $3,682 · Consulting Fee: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,935.77 |
| Travel and Lodging | $3,681.76 |
| Consulting Fee | $498.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $3,600.00 | 2021-2022 | |
| Arthrex, INC. | $2,864.97 | 2023-2025 | |
| Stryker Corporation | $2,186.54 | 2022-2025 | Mako, 7 X 23mm Citrelock Implant, Infinity |
| Paragon 28, INC. | $1,730.80 | 2023-2025 | Portfolio, Phantom Fibula Nail, Additive Orthopedics |
| Polaris Technology Solutions LLC | $992.31 | 2024-2025 | |
| Supreme Orthopedic Systems, LLC | $463.33 | 2023 | |
| Exactech, INC. | $347.74 | 2024 | |
| My01 INC. | $261.46 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Treace Medical Concepts, INC. | $144.54 | 2025 | |
| Orthalign INC | $75.13 | 2023 | Orthalign Plus |
| Depuy Synthes Sales INC. | $21.38 | 2025 | Monovisc |
| Biocomposites INC | $15.78 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amos Dai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.